Desafios da indústria farmacêutica brasileira

The paper traces a panorama of the development of new drugs and hopes to contribute for Brazil to become a player in the discovery of new drugs. Brazil is the sixth world market retail consumer of medicines prone to expansion, has a pharmaceutical industry focused on the production of generics and a very large number of undergraduate courses in Pharmacy. The national industry has grown over the last decade after the Generics Act 9787/99. Despite these positive aspects, a number of bottlenecks prevent Brazilian pharmaceutical industry to invest in the development of new drugs. There are, however, a number of initiatives to reduce the dependence on imported generic drugs. It is a very good start for the development of new pharmaceutical drugs.

Saved in:
Bibliographic Details
Main Authors: Pinto,Angelo C., Barreiro,Eliezer J.
Format: Digital revista
Language:Portuguese
Published: Sociedade Brasileira de Química 2013
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422013001000012
Tags: Add Tag
No Tags, Be the first to tag this record!